Insider10% Owner
Ansbert Gadicke Insider Trading Activity
Every SEC Form 4 transaction reported by Ansbert Gadicke, sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Is Ansbert Gadicke buying or selling?
Ansbert Gadicke reported 8 open-market buys ($78.8M) and 64 sells ($131.4M) across 72 Form 4 filings at 8 companies — a net selling position of $52.6M.
Source: SEC EDGAR Form 4
What stands out
- Ansbert Gadicke has reported Form 4 transactions at 8 companies; the most active, iTeos Therapeutics, Inc. (ITOS), accounts for 20 of 72 filings (28%).
- The most recent Form 4 was accepted on Jan 14, 2026 (9 months ago).
- In the last 12 months: 1 open-market purchase ($20.0M) and 9 sales ($2.2M).
- The largest open-market purchase in the last 12 months was $20.0M of Aktis Oncology, Inc. (AKTS) on Jan 14, 2026. SEC ↗
Key Statistics (as of Jan 14, 2026)
Total Form 4 filings
72
SEC EDGAR
Companies
8
Buys (8)
$78.8M
Sells (64)
$131.4M
Insider sentiment
Net sellingNet insider flow of $52.6M in net selling, filed between Feb 14, 2019 – Jan 14, 2026.
Companies Ansbert Gadicke files for
Recent Ansbert Gadicke transactions
| Date | Ticker | Role | Type | Shares | Value | Filing |
|---|---|---|---|---|---|---|
| Jan 14, 2026 | AKTS | 10% Owner | Purchase | 1.1M | $20.0M | SEC ↗ |
| Dec 4, 2025 | HOWL | Other | Sale | 199.7K | $183.3K | SEC ↗ |
| Dec 1, 2025 | HOWL | 10% Owner | Sale | 141.9K | $136.9K | SEC ↗ |
| Nov 25, 2025 | HOWL | 10% Owner | Sale | 195.7K | $179.6K | SEC ↗ |
| Nov 20, 2025 | HOWL | 10% Owner | Sale | 160.1K | $147.9K | SEC ↗ |
| Nov 18, 2025 | HOWL | 10% Owner | Sale | 209.7K | $200.7K | SEC ↗ |
| Nov 13, 2025 | HOWL | 10% Owner | Sale | 213.5K | $241.3K | SEC ↗ |
| Nov 7, 2025 | HOWL | 10% Owner | Sale | 242.9K | $295.8K | SEC ↗ |
| Nov 4, 2025 | HOWL | 10% Owner | Sale | 295.0K | $391.6K | SEC ↗ |
| Oct 29, 2025 | HOWL | 10% Owner | Sale | 276.0K | $446.4K | SEC ↗ |
| May 15, 2025 | ITOS | Other | Sale | 1.0M | $8.3M | SEC ↗ |
| Apr 30, 2025 | HOWL | 10% Owner | Sale | 4.4K | $4.6K | SEC ↗ |
| May 24, 2023 | TCRR | Director, 10% Owner | Sale | 70.2K | $131.9K | SEC ↗ |
| Jan 6, 2022 | ITOS | 10% Owner | Sale | 245.5K | $10.5M | SEC ↗ |
| Dec 7, 2021 | ITOS | 10% Owner | Sale | 83.4K | $2.8M | SEC ↗ |
| Dec 2, 2021 | ITOS | 10% Owner | Sale | 139.8K | $4.8M | SEC ↗ |
| Nov 30, 2021 | ITOS | 10% Owner | Sale | 38.6K | $1.4M | SEC ↗ |
| Nov 24, 2021 | ITOS | 10% Owner | Sale | 129.6K | $4.7M | SEC ↗ |
| Oct 18, 2021 | ITOS | 10% Owner | Sale | 28.6K | $785.4K | SEC ↗ |
| Oct 14, 2021 | ITOS | 10% Owner | Sale | 95.0K | $2.6M | SEC ↗ |
| Oct 12, 2021 | ITOS | 10% Owner | Sale | 87.0K | $2.4M | SEC ↗ |
| Oct 5, 2021 | ITOS | 10% Owner | Sale | 46.1K | $1.2M | SEC ↗ |
| Sep 30, 2021 | ITOS | 10% Owner | Sale | 36.0K | $971.7K | SEC ↗ |
| Sep 27, 2021 | ITOS | 10% Owner | Sale | 89.5K | $2.5M | SEC ↗ |
| Sep 23, 2021 | ITOS | 10% Owner | Sale | 56.8K | $1.6M | SEC ↗ |
Showing the 25 most recent filings of 72. Screen every filing.
Ansbert Gadicke insider trading FAQ
Is Ansbert Gadicke buying or selling?
Across 72 SEC Form 4 filings, Ansbert Gadicke reported 8 open-market purchases totaling $78.8M and 64 sales totaling $131.4M — a net selling position of $52.6M.
Which companies does Ansbert Gadicke file Form 4s for?
Ansbert Gadicke has reported insider transactions at 8 companies, most often iTeos Therapeutics, Inc. (ITOS), Harpoon Therapeutics, Inc. (HARP), Repare Therapeutics Inc. (RPTX), Werewolf Therapeutics, Inc. (HOWL), Cullinan Oncology, Inc. (CGEM).
How far back does Ansbert Gadicke's filing history go?
Trabud holds Ansbert Gadicke's SEC Form 4 filings from Feb 14, 2019 – Jan 14, 2026, sourced directly from SEC EDGAR.
Where does Trabud get Ansbert Gadicke's insider trading data?
Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.
Related Content
Track Ansbert Gadicke and every other insider
Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.
Open the screener